<DOC>
<DOCNO>
EP-0009465
</DOCNO>
<TEXT>
<DATE>
19800402
</DATE>
<IPC-CLASSIFICATIONS>
C07D-211/00 C07D-491/04 C07D-401/14 A61P-9/00 C07D-491/00 A61P-9/12 C07D-211/88 A61K-31/4427 A61K-31/445 C07D-401/00 C07D-491/056 
</IPC-CLASSIFICATIONS>
<TITLE>
n-(1-(4-amino-2-quinazolinyl)-3 or 4-piperidyl lactames, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
ciba geigy agch<sep>ciba-geigy ag<sep>ciba-geigy agklybeckstrasse 1414002 baselch<sep>
</APPLICANT>
<INVENTOR>
werner lincoln harvey drus<sep>werner, lincoln harvey, dr.<sep>werner, lincoln harvey, dr.94 larned roadsummit new jersey, 07901us<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to hypotensive and antihypertensi Ve compounds of formula I wherein pH is a 1,2-phenylene radical, which may be selected by at most 3 substituents selected from Niederal Kyl and Lower Alkoxy and a lower alkyl dioxide sub, each of the symbols M and N for a wholeNumber from 1 to 3, wherein M + N = 4, x 2 of water means fabric atoms or oxo, and A for lower alkylene, 4 to 7 ring members containing cycloalkylene, cycloalkylnie the alkyls and spirocycloalkane-lower alkylene, HPH-lower alkylene or pH, andYour acid addition salts.They can be prepared by reacting 2-halogen chlnazolines with corresponding piperidine compounds.
</ABSTRACT>
</TEXT>
</DOC>
